搜索临床试验以:CDK 抑制剂 AT7519
总计65538个结果
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Allergy and Infectious Diseases (NIAID)邀请报名
-
Beijing GoBroad Hospital尚未招聘急性淋巴细胞白血病,复发 | 难治性急性淋巴细胞白血病 | T细胞急性淋巴细胞白血病
-
HealthPartners InstituteKaiser Permanente; Children's Hospitals and Clinics of Minnesota完全的
-
Hunan Cancer Hospital尚未招聘乳腺癌 | 内分泌治疗 | CDK4/6 抑制剂 | 后续治疗
-
Chong Kun Dang Pharmaceutical尚未招聘
-
Singh, Ranjan Kumar, M.D.完全的
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First People's Hospital of Hefei; Hefei Binhu Hospital未知急性髓性白血病 | 血管免疫母细胞性T细胞淋巴瘤 | 肝脾T细胞淋巴瘤 | 前体 T 细胞淋巴细胞白血病-淋巴瘤 | 结外 NK/T 细胞淋巴瘤,鼻型 | T 细胞幼淋巴细胞白血病 | T 细胞大颗粒淋巴细胞白血病 | 外周 T 细胞淋巴瘤,NOS | 肠病型肠T细胞淋巴瘤中国
-
University Hospital HeidelbergAmsterdam Institute for Global Health and Development; Swiss Tropical & Public Health Institute 和其他合作者招聘中
-
Seoul National University HospitalEnsol Biosciences, Inc.完全的
-
St. Antonius HospitalMaasstad Hospital完全的
-
Xuanwu Hospital, BeijingBaoding Children's Hospital招聘中
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)完全的
-
Electrochemical Oxygen Concepts, Inc.完全的
-
Chong Kun Dang Pharmaceutical完全的
-
Kaiser PermanenteUniversity of California, San Francisco; OCHIN, Inc.主动,不招人
-
University of RochesterNational Institutes of Health (NIH)尚未招聘
-
HealthPartners InstituteNational Heart, Lung, and Blood Institute (NHLBI)完全的